ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Thoracic Portal

Pages

Filmed at the 2019 AATS Annual Meeting in Toronto, Canada, Mara Antonoff of the University of Texas MD Anderson Cancer Center in Houston, USA, moderates a discussion on dedicated research time for... More
April 8, 2008
Obstruction of the central airways may develop in 30-40% of all patients with lung cancer and is being increasingly diagnosed in patients with benign disorders such as post intubation tracheal stenosis and connective tissue diseases.
April 8, 2008
Radio frequency ablation (RFA) of lung tumors is a relatively new procedure allowing local treatment with minimal parenchymal damage. In fact, this technique is able to induce coagulative necrosis in a limited pulmonary area.
April 8, 2008
Tissue sealing remains a requirement for advanced general thoracic procedures with the aims of improving hemostasis, diminishing lymphatic fluid production, and prevention of postoperative air leaks.  Different products have become available in recent years that include commercial biological glues, autologous glues made on-site, and biological fibrin-based products.
April 8, 2008
Pulmonary nodules and masses are common reasons for referring patients to the pulmonologist, radiologist, and thoracic surgeon for evaluation. The burgeoning use of chest computed tomography for screening, to rule out pulmonary embolism, and for other indications may lead to a significant increase in patients with newly discovered lesions.
April 8, 2008
The impetus for intrabronchial treatment of emphysema came from the experiences with lung volume reduction surgery (LVRS).
April 7, 2008
Approaches to lung resection for early stage cancer.
April 7, 2008
Practice patterns of surgical therapy for esophageal cancer
April 16, 2006
Emphysema affects an estimated 60 million people worldwide. It is a disease associated with significant morbidity in the form of dyspnea and exercise limitation and mortality. The pathology behind this is the destruction of pulmonary parenchyma, both alveolar walls and interstitial tissue.

Pages